Anti-hypertensive drugs

The latest evidence does not have evidence of an effect due to discontinuing vs
continuing medications used for treating elevated blood pressure or prevention of
heart disease in older adults on all-case mortality and incidence of heart attack.
[14] The findings are based on low quality evidence suggesting it may be safe to
stop anti-hypertensive medications. However, older adults should not stop any of
their medications without talking to a healthcare professional.[14]

See also
Chemical dependency
Craving, a psychological withdrawal symptom
Drug detoxification
Drug tolerance
Hangover
Neonatal withdrawal
Rebound effect
Post-acute withdrawal syndrome (PAWS)
References
"MeSH Browser". meshb.nlm.nih.gov. Archived from the original on 30 July 2020.
Retrieved 7 February 2020.
Koob GF (May 1996). "Drug addiction: the yin and yang of hedonic homeostasis".
Neuron. 16 (5): 893–6. doi:10.1016/S0896-6273(00)80109-9. PMID 8630244. S2CID
7053540.
"What Causes Drug Withdrawal?". Laguna Treatment Hospital. Archived from the
original on 2018-10-13. Retrieved 2018-10-12.
Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 15: Reinforcement and Addictive
Disorders". In Sydor A, Brown RY (eds.). Molecular Neuropharmacology: A Foundation
for Clinical Neuroscience (2nd ed.). New York: McGraw-Hill Medical. pp. 364–375.
ISBN 9780071481274.
Nestler EJ (December 2013). "Cellular basis of memory for addiction". Dialogues in
Clinical Neuroscience. 15 (4): 431–443. PMC 3898681. PMID 24459410. Despite the
importance of numerous psychosocial factors, at its core, drug addiction involves a
biological process: the ability of repeated exposure to a drug of abuse to induce
changes in a vulnerable brain that drive the compulsive seeking and taking of
drugs, and loss of control over drug use, that define a state of addiction. ... A
large body of literature has demonstrated that such ΔFosB induction in D1-type
[nucleus accumbens] neurons increases an animal's sensitivity to drug as well as
natural rewards and promotes drug self-administration, presumably through a process
of positive reinforcement ... Another ΔFosB target is cFos: as ΔFosB accumulates
with repeated drug exposure it represses c-Fos and contributes to the molecular
switch whereby ΔFosB is selectively induced in the chronic drug-treated
state.41. ... Moreover, there is increasing evidence that, despite a range of
genetic risks for addiction across the population, exposure to sufficiently high
doses of a drug for long periods of time can transform someone who has relatively
lower genetic loading into an addict.
"Glossary of Terms". Mount Sinai School of Medicine. Department of Neuroscience.
Retrieved 9 February 2015.
Volkow ND, Koob GF, McLellan AT (January 2016). "Neurobiologic Advances from the
Brain Disease Model of Addiction". New England Journal of Medicine. 374 (4): 363–
371. doi:10.1056/NEJMra1511480. PMC 6135257. PMID 26816013. Substance-use disorder:
A diagnostic term in the fifth edition of the Diagnostic and Statistical Manual of
Mental Disorders (DSM-5) referring to recurrent use of alcohol or other drugs that
causes clinically and functionally significant impairment, such as health problems,
disability, and failure to meet major responsibilities at work, school, or home.
Depending on the level of severity, this disorder is classified as mild, moderate,
or severe.
Addiction: A term used to indicate the most severe, chronic stage of substance-use
disorder, in which there is a substantial loss of self-control, as indicated by
compulsive drug taking despite the desire to stop taking the drug. In the DSM-5,
the term addiction is synonymous with the classification of severe substance-use
disorder.
"Opiate and opioid withdrawal". MedlinePlus Medical Encyclopedia. U.S. National
Library of Medicine. Archived from the original on 2019-12-08. Retrieved 2019-11-
20.
Peter Lehmann, ed. (2002). Coming off Psychiatric Drugs. Germany: Peter Lehmann
Publishing. ISBN 978-1-891408-98-4. Archived from the original on 2019-05-28.
Retrieved 2022-05-06.
Joint Formulary Committee, BMJ, ed. (March 2009). "4.2.1". British National
Formulary (57 ed.). United Kingdom: Royal Pharmaceutical Society of Great Britain.
p. 192. ISBN 978-0-85369-845-6. Withdrawal of antipsychotic drugs after long-term
therapy should always be gradual and closely monitored to avoid the risk of acute
withdrawal syndromes or rapid relapse.
Alexander GC, Sayla MA, Holmes HM, Sachs GA (April 2006). "Prioritizing and
stopping prescription medicines". CMAJ. 174 (8): 1083–4. doi:10.1503/cmaj.050837.
PMC 1421477. PMID 16606954.
"MATCH-D Medication Appropriateness Tool for Comorbid Health conditions during
Dementia". www.match-d.com.au. Archived from the original on 2019-05-18. Retrieved
2